-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
-
Warfarin is the second-most-likely drug, to cause adverse events requiring hospitalization. The use of warfarin sensitivity testing in the U.S. could avoid 85,000 serious-bleeding incidents. More in the way of personalized medicine and if you were a patient determined to have an adverse reaction...
-
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
-
Intel and other venture capitalists seem to like the genomics business too. Personalized medicine holds the key to many areas of Pharmacogenomics and where healthcare is headed. Genomic sequencing stands to unlock many areas of information that will lead us to which drugs and combinations...
-
We all recently heard about the warning letters sent from the state of California to firms selling online personal DNA sequencing over the Internet, and requiring a physician’s prescription for the service. One company DeCode, has taken the letter to heart and is revising their marketing plant...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-12-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, DNA, Genomics, Sequence, Pharmacogenomics, Diagnostics, CPT, DeCode
-
When will it start paying the bills? The science and development is somewhat fragmented like the rest of health care, and this is not to say in any way that phenomenal breakthroughs are not occurring by any means as they are. Part of the problem is having enough data, real time data for one...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-03-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, My Commentaries, Physician, personalized medicine, DNA, Genomics, healthcare, Science, Pharmacogenomics
-
Perhaps a come back for California who slipped in the recent technology ratings, but more importantly the recent news with online DNA companies not being able to perform services in the state of California without a prescription from a physician may in turn contribute to making this a fit, since they...
-
The company, Accium Biosciences runs a device called a spectrometer, and it qualifies the amount of c-14, present in a sample, so what does all this mean? The sample gives information relative to the drug makers as to how the drugs are working, big news coinciding with personalized medicine. This...
-
Coriell University will begin offering free tests for 10,000 participants, and included is the education process to help both patients and physicians know what to do with the information. The Coriell project will offer a narrower range of results, and it will make a direct effort to involve...
-
This is a good article from Medscape and well worth reading...you will need to set up a log on account to read the entire article...basically it explains the changes that are taking place today and what is in store for the future..it will be a big change for big pharma not only in R and D, but marketing...
-
The recent turn of events has literally put the FDA on somewhat of a hot seat... for an agency that minimally invested in technology, compared to other government entities, it is finding itself in a position of having to play "catch up" in a hurry...as evidenced with the recent turn of events...
-
If you have not read up yet on personalized medicine this is a great article that will go through the basics in layman's terms...there are 4 links below to each section...and the last area is the toughest...the challenges as it will all be work in progress for quite a while to come...so somebody...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-24-2008
Filed under:
Filed under: Medically Related, Technology, Insurance, Pharma/FDA News, Labs, personalized medicine, Medicine, DNA, Biotech, healthcare providers, Advocates
-
You set up a profile and play against others on the Internet..." The more we know about how certain proteins fold, the better new proteins we can design to combat the disease-related proteins and cure the diseases.". The project has been given a grant of 20 Million from the Bill and Melinda...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
05-11-2008
Filed under:
Filed under: Medically Related, Technology, Other Items of Interest, Games, personalized medicine, DNA, Genomics, Disease Research, FoldIt, University of Washington, Proteins